StockNow
Calendar
Log in
U.S. Markets

Hims & Hers Health Inc. (HIMS) Q3 2026 (USD) EPS -0.14 (exp. 0.06), Revenue 890mln (exp. 893mln)

ORIGINAL · NewsquawkHims & Hers Health Inc. (HIMS) Q3 2026 (USD) EPS -0.14 (exp. 0.06), Revenue 890mln (exp. 893mln)Read originalHide original

Sees Q4 Adj. EBITDA USD 70mln-90mln (exp. 84.7mln) Sees Q4 rev. USD 875mln-895mln (exp. 953.8mln). Sees FY Adj. EBITDA USD 257mln-277mln (exp. 294.6mln) Sees FY rev. USD 3.13bln-3.15bln (exp. 3.21bln).

StockNow breaking-news AI analysis

Q3 EPS and revenue were reported against expectations; Q4 and full-year revenue and adjusted EBITDA outlook ranges were also provided against expectations.

News detail

Sees Q4 Adj. EBITDA USD 70mln-90mln (exp. 84.7mln) Sees Q4 rev. USD 875mln-895mln (exp. 953.8mln). Sees FY Adj. EBITDA USD 257mln-277mln (exp. 294.6mln) Sees FY rev. USD 3.13bln-3.15bln (exp. 3.21bln).

1 stocks
HIMSHims & Hers Health, Inc.$22.73Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Nvidia (NVDA) CEO's relationship with Alice Huang dated back to at least 2023 and facillitated the sale of at least USD 7.5bln in Nvidia chips to China, The Information reports citing sources

NVDAGeopolitics

An Iranian diplomatic source denies reports of an agreement with the US on uranium enrichment at 3.67% or other nuclear issues, insisting Tehran's two-day proposal remains unchanged and no detailed nuclear discussions have taken place, according to Avash

Geopolitics

Iranian Foreign Minister Araghchi says there are no plans for a meeting between Supreme National Security Council chief Mohsen Rezaei and US Vice President Vance, Al Mayadeen reports